Emerging and Experimental Agents for Anal Cancer: What is New?

Autor: Farias JPF, Rangel da Silva MHC, Jácome AA

Publikováno v: Journal of Experimental Pharmacology, Vol Volume 13, Pp 433-440 (2021)

João Paulo F Farias,1 Maria Helena C Rangel da Silva,2 Alexandre A Jácome2 1Department of Gastrointestinal Medical Oncology, Oncoclínicas, Rio de Janeiro, Brazil; 2Department of Gastrointestinal Medical Oncology, Oncoclínicas, Belo Horizonte, Bra

Externí odkaz: https://doaj.org/article/d31fce8783054e249447a747ed7912da

Risk of Cancer in Inflammatory Bowel Disease and Pitfalls in Oncologic Therapy.

Autor: Peixoto RD; Instituto Oncoclínicas, São Paulo, SP, Brazil. renatadalpino@gmail.com., Ferreira AR; Instituto Oncoclínicas, São Paulo, SP, Brazil., Cleary JM; Dana farber cancer institute, Boston, MA, 02215, USA., Fogacci JP; Instituto Oncoclínicas, São Paulo, SP, Brazil., Vasconcelos JP; Instituto Oncoclínicas, São Paulo, SP, Brazil., Jácome AA; Instituto Oncoclínicas, São Paulo, SP, Brazil.

Publikováno v: Journal of gastrointestinal cancer [J Gastrointest Cancer] 2023 Jun; Vol. 54 (2), pp. 357-367. Date of Electronic Publication: 2022 Mar 14.

Biologics in rectal cancer.

Autor: Jácome AA; Department of Gastrointestinal Medical Oncology, Oncoclínicas, Belo Horizonte, Brazil., Peixoto RD; Department of Gastrointestinal Medical Oncology, Oncoclínicas, São Paulo, Brazil., Gil MV; Department of Gastrointestinal Medical Oncology, Oncoclínicas, Rio de Janeiro, Brazil., Ominelli J; Department of Gastrointestinal Medical Oncology, Oncoclínicas, Rio de Janeiro, Brazil., Prolla G; Department of Gastrointestinal Medical Oncology, Oncoclínicas, Porto Alegre, Brazil., Dienstmann R; Oncoclínicas Precision Medicine, São Paulo, Brazil., Eng C; Department of Medicine, Division of Hematology and Oncology, Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA.

Publikováno v: Expert opinion on biological therapy [Expert Opin Biol Ther] 2022 Oct; Vol. 22 (10), pp. 1245-1257. Date of Electronic Publication: 2022 Aug 03.

Anal Cancer: Emerging Standards in a Rare Disease.

Autor: Eng C; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN., Ciombor KK; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN., Cho M; Division of Hematology and Oncology, Department of Medicine, University of California- Irvine School of Medicine, Irvine, CA., Dorth JA; Department of Radiation Oncology, Seidman Cancer Center, University Hospitals Cleveland Medical Center, Cleveland, OH., Rajdev LN; Division for Hematology and Oncology, Department of Medicine, Northwell Health/Lenox Hill Hospital, New York, NY., Horowitz DP; Department of Radiation Oncology, New York Presbyterian Hospital/Columbia University Irving Medical Center, New York, NY., Gollub MJ; Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY., Jácome AA; OncoBio Comprehensive Cancer Center, Department of Gastrointestinal Medical Oncology, Nova Lima, Brazil., Lockney NA; Department of Radiation Oncology, Vanderbilt University Medical Center, Nashville, TN., Muldoon RL; Division of Colon and Rectal Surgery, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN., Washington MK; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN., O'Brian BA; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN., Benny A; Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University Medical Center/Vanderbilt-Ingram Cancer Center, Nashville, TN., Lebeck Lee CM; VA Tennessee Valley Healthcare System, Department of Internal Medicine, Nashville, TN., Benson AB 3rd; Division of Hematology-Oncology, Northwestern University, Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center, Chicago, IL., Goodman KA; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY., Morris VK; Division of Cancer Medicine, Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Aug 20; Vol. 40 (24), pp. 2774-2788. Date of Electronic Publication: 2022 Jun 01.

A comprehensive framework for early-onset colorectal cancer research.

Autor: Eng C; Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA. Electronic address: cathy.eng@vumc.org., Jácome AA; OncoBio Comprehensive Cancer Center, Oncoclinicas, Belo Horizonte, Brasil., Agarwal R; Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA., Hayat MH; Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN, USA., Byndloss MX; Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Holowatyj AN; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA., Bailey C; Division of Surgical Oncology and Endocrine Surgery, Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, USA., Lieu CH; Division of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado, USA.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2022 Mar; Vol. 23 (3), pp. e116-e128. Date of Electronic Publication: 2022 Jan 31.